Mave Health

founder and ceo @mavehealth

Mave Health makes a consumer headset that uses transcranial direct current stimulation to support focus, mood, and stress regulation. The wearable delivers gentle, targeted stimulation designed to support prefrontal cortex activity and overall mental performance , with 20-minute daily sessions aimed at people who want a non-pharmaceutical option for everyday cognitive load. The underlying tDCS technology has been studied for over 25 years, with more than 10,000 published papers globally , and the device does not collect brain data , which sets it apart from EEG-style consumer neurotech. This launch kicks off a "Maverick" campaign featuring real users who have lived with the headset. The first profile is UFC welterweight Max "Pain" Griffin, who used the device for roughly 100 days for stress regulation and performance, with the company citing a brain score change from 71 to 83.4 over the first 30 days. The framing in the launch video, that stress hits the same whether you are in the cage or the cubicle, signals a positioning push beyond athletes toward knowledge workers and operators dealing with chronic overload. The company is led by CEO Dhawal Jain, who co-founded Mave Health with Jai Sharma, a BITS-Pilani alumnus, and Aman Kumar . Mave is based in San Francisco and prices the headset at $495 , and the company recently raised $2.1M to launch the focus and stress regulation wearable . For founders and operators tracking the consumer neurotech space, this launch matters because it pairs a shipping hardware product with a clinical-adjacent technique that has historically lived in research labs, and it tests whether a tDCS device can build a mainstream brand on user testimonials rather than clinical claims alone.

Tags

Comments (12)